VP Bank in Asia makes two newly-created key appointments to its Asia Management Committee

5 years ago

SINGAPORE - Media OutReach - 20 September 2021 - VP Bank has today announced the appointments of Alexander Tsikouras as Chief Financial Officer & Chief…

Signitory – A Glimpse Into the Future Through a Blockchain-Based eSignature Solution

5 years ago

KUALA LUMPUR, MALAYSIA - Media OutReach - 20 September 2021 - With the growth of e-commerce, more and more individuals are becoming accustomed…

Brands Eyeing Chinese Expats in Singapore to Fuel Sales Post-COVID-19

5 years ago

As retail sales steadily recover, Chinese Expats have renewed their strong shopping sentiment with 63% spending more post COVID-19: EternityX…

Montréal Exchange Extends Trading Hours to Asia Pacific Time Zones

5 years ago

Canada’s Derivatives Exchange further expands global reach, syncing trading hours with Asia Pacific markets in support of growing investor demand…

Fusionex Signs MoU with Alliance Islamic Bank to Accelerate SMEs’ Halal Business Growth

5 years ago

PETALING JAYA, Malaysia--(BUSINESS WIRE)--#AllianceIslamicBank--Artificial Intelligence and Big Data technology market leader Fusionex recently signed an MoU with Alliance Islamic Bank…

Rio Tinto to triple Weipa solar capacity and add battery storage to help power operations

5 years ago

MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has approved a new solar farm and battery storage at Weipa in Queensland, in a move…

Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations

5 years ago

Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2…

Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)

5 years ago

 The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19…

ENHERTU® Demonstrated Robust and Durable Tumor Response of 54.9% in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer

5 years ago

First HER2 directed therapy to show a strong tumor response in this population Data from HER2 mutant cohort of pivotal…

Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering

5 years ago

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based investment management software and services,…